Structure of the Measles Virus Fusion Glycoprotein Ectodomain in Prefusion Conformation Bound to Neutralizing Antibody H8
Zyla, D., Niemeyer, G., Porotto, M., Saphire, E.O.To be published.
Experimental Data Snapshot
Starting Models: experimental, in silico
View more details
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Fusion glycoprotein F0 | 532 | Measles morbillivirus | Mutation(s): 0  | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | Q786F3 | ||||
Glycosylation | |||||
| Glycosylation Sites: 3 | |||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Mab H8 heavy chain | G, I [auth J], K [auth L] | 476 | Mus musculus | Mutation(s): 0  | ![]() |
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| mAb H8 light chain | H [auth I], J [auth K], L [auth M] | 236 | Mus musculus | Mutation(s): 0  | ![]() |
Entity ID: 4 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Length | 2D Diagram | Glycosylation | D Interactions |
| beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | M [auth H] | 3 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan: G15407YE GlyCosmos: G15407YE GlyGen: G15407YE | |||||
Entity ID: 5 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Length | 2D Diagram | Glycosylation | D Interactions |
| 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | N, P, R | 2 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan: G42666HT GlyCosmos: G42666HT GlyGen: G42666HT | |||||
Entity ID: 6 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Length | 2D Diagram | Glycosylation | D Interactions |
| alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | O, Q | 5 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan: G22768VO GlyCosmos: G22768VO GlyGen: G22768VO | |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| NAG Download:Ideal Coordinates CCD File | S [auth A], T [auth C], U [auth E] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
| Task | Software Package | Version |
|---|---|---|
| MODEL REFINEMENT | PHENIX | 2.0_5793 |
| RECONSTRUCTION | cryoSPARC |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Swiss National Science Foundation | Switzerland | P2EZP3_195680 |
| Swiss National Science Foundation | Switzerland | P500PB_210992 |
| National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) | United States | NS105699 |
| National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) | United States | NS091263 |
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | AI176833 |
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | 1R56AI183536-01A1 |
| National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) | United States | 5R21AI180456-02 |